Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 309, Issue 5, Pages G301-G309
Publisher
American Physiological Society
Online
2015-07-04
DOI
10.1152/ajpgi.00010.2015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles
- (2015) Sara Lemoinne et al. HEPATOLOGY
- Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma
- (2015) Ambrish Kumar et al. Oncotarget
- A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury
- (2014) Diana Hide et al. CLINICAL SCIENCE
- Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
- (2014) Xiaodan Zhang et al. HEPATOLOGY
- Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia
- (2014) Yan Liu et al. Lipids in Health and Disease
- Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis
- (2013) María Gabriela Delgado et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats
- (2013) Eugenio Rosado et al. HEPATOLOGY
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- Functional aspects on the pathophysiology of portal hypertension in cirrhosis
- (2012) Juan-Carlos García-Pagán et al. JOURNAL OF HEPATOLOGY
- Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
- (2012) Maeva Guillaume et al. JOURNAL OF HEPATOLOGY
- Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
- (2012) Marco Di Pascoli et al. JOURNAL OF HEPATOLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
- (2012) Yuki Kita et al. PLoS One
- Liver cirrhosis
- (2011) Massimo Pinzani et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Metformin restores endothelial function in aorta of diabetic rats
- (2011) Cristina M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- Insulin resistance and liver microcirculation in a rat model of early NAFLD
- (2011) Marcos Pasarín et al. JOURNAL OF HEPATOLOGY
- Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats
- (2011) Ying-Ying Yang et al. LIVER INTERNATIONAL
- Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway
- (2010) Han Xiao et al. CARDIOVASCULAR RESEARCH
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats
- (2010) Cheng-Xi Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
- (2010) J. Gracia-Sancho et al. GUT
- Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats
- (2010) Héctor García-Calderó et al. JOURNAL OF HEPATOLOGY
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension
- (2009) C Agard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes
- (2008) Takayuki Matsumoto et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat
- (2008) Giuseppina Mattace Raso et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension
- (2008) B Lavina et al. GUT
- Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis
- (2008) Ying-Ying Yang et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started